Showing results (191-200 of 330) with videos related to
Sort By:
Pageof 33
Psychiatric Genetics|December 23, 1998
Parent-of-origin effect and evidence for differential transmission in periodic catatoniaG Stöber, I Haubitz, E Franzek, et al.Psychiatry Research|September 1, 1988
Endocrine parameters and biogenic amines in relationship to psychopathology after cholinergic drug challenge (RS-86)J Fritze, E Sofic, P Riederer, et al.Archives of General Psychiatry|November 1, 1991
Hippocampal neuron number in schizophrenia. A stereological studyS Heckers, H Heinsen, B Geiger, et al.Biological Psychiatry|March 15, 1991
Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem studyS Heckers, H Heinsen, Y Heinsen, et al.Schizophrenia Research|June 20, 2000
Decreased S100-beta protein in schizophrenia: preliminary evidenceW F Gattaz, D R Lara, H Elkis, et al.Journal of Thrombosis and Haemostasis : JTH|March 23, 2016
Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samplesS Kitchen, Y Katterle, H Beckmann, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Periodic catatonia: a schizophrenic subtype with major gene effect and anticipationG Stöber, E Franzek, K P Lesch, et al.Zentralblatt Fur Chirurgie|May 23, 2013
[Immunological Markers in Organ Transplantation]J H Beckmann, N Heits, F Braun, et al.Acta Psychiatrica Scandinavica|June 9, 2012
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorderM G Soeiro-de-Souza, V V Dias, M L Figueira, et al.Archiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1981
Platelet monoamine oxidase in healthy subjects: the "biochemical high-risk paradigm" revisitedP Propping, E R Rey, W Friedl, et al.Pageof 33